Seven steps to synthesize Peficitinib hydrobromide
Peficitinib is a Janus kinase (JAK)1, JAK2, JAK3, and tyrosine kinase (Tyk)2 (pan-JAK) inhibitor recently approved in Japan for the treatment of rheumatoid arthritis.
Jan 11，2024
